Professor Vice Chair, Department of Ophthalmology and Gavin Herbert Eye Institute UCI School of Medicine Irvine, California
Frequently under-recognized and burdensome, dry eye disease (DED) can significantly impact quality of life, with a large percentage of patients routinely experiencing exacerbations of the disorder known as dry eye flares. There is a need for newer therapeutic options that can address the underlying effects of DED while also offering patients an earlier onset of observable clinical effect. This insightful session will help eye care specialists become better educated on proper identification techniques, triggering factors, treatment barriers, and monitoring strategies for dry eye, while also discussing therapies available to optimize patient outcomes.
This activity is supported by an independent educational grant from Kala Pharmaceuticals
Learning Objectives:
Describe the pathophysiology, epidemiology, etiology, risk factors, burden, and clinical presentation of dry eye disease and flares
Evaluate the clinical safety and efficacy profiles associated with treatment options for the long- and short-term management of dry eye disease and flares
Implement individualized management strategies to overcome treatment barriers that contribute to suboptimal dry eye outcomes
